Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Tactile Systems Technology Inc is a medical devices business based in the US. Tactile Systems Technology shares (TCMD) are listed on the NASDAQ and all prices are listed in US Dollars. Tactile Systems Technology employs 988 staff and has a trailing 12-month revenue of around $221.8 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $8.02 |
|---|---|
| 52-week range | $6.28 - $46.41 |
| 50-day moving average | $8.62 |
| 200-day moving average | $13.50 |
| Wall St. target price | $23.33 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.27 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.02 from 2022-09-29
| 1 week (2022-09-23) | 6.51% |
|---|---|
| 1 month (2022-09-01) | -2.31% |
| 3 months (2022-07-01) | 14.25% |
| 6 months (2022-03-29) | -60.61% |
| 1 year (2021-10-01) | -82.54% |
|---|---|
| 2 years (2020-10-01) | -78.25% |
| 3 years (2019-10-01) | 41.39 |
| 5 years (2017-09-29) | 30.95 |
Valuing Tactile Systems Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tactile Systems Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tactile Systems Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 17.236. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tactile Systems Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $221.8 million |
|---|---|
| Gross profit TTM | $148.2 million |
| Return on assets TTM | -4.95% |
| Return on equity TTM | -25.17% |
| Profit margin | -14% |
| Book value | $5.67 |
| Market capitalisation | $151.6 million |
TTM: trailing 12 months
We're not expecting Tactile Systems Technology to pay a dividend over the next 12 months.
Over the last 12 months, Tactile Systems Technology's shares have ranged in value from as little as $6.28 up to $46.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tactile Systems Technology's is 1.4471. This would suggest that Tactile Systems Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Tactile Systems Technology, Inc. , a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. .
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.